Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041911 | SCV000065607 | benign | not specified | 2012-02-20 | criteria provided, single submitter | clinical testing | Thr2528Thr in exon 40 of USH2A: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 3.2% (119/3738) of A frican American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs .washington.edu/EVS/; dbSNP rs78250390). |
Prevention |
RCV000041911 | SCV000317212 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000041911 | SCV000730473 | benign | not specified | 2017-03-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000087014 | SCV001029862 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450889 | SCV004183231 | benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450888 | SCV004183232 | benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000087014 | SCV005280568 | benign | not provided | criteria provided, single submitter | not provided | ||
NEI Ophthalmic Genomics Laboratory, |
RCV000087014 | SCV000119267 | not provided | not provided | no assertion provided | not provided |